The stock of Cryoport Inc. (NASDAQ:CYRX) last traded at $22.86, up 9.77% from the previous session.
CYRX stock price is now 22.18% away from the 50-day moving average and -15.69% away from the 200-day moving average. The market capitalization of the company currently stands at $1.10B.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
With the price target maintained at $90, ROTH Capital recently Upgraded its rating from Neutral to Buy for Cryoport Inc. (NASDAQ: CYRX). On November 05, 2021, ROTH Capital Downgraded its previous ‘Buy’ rating to ‘Neutral’ on the stock increasing its target price from $78 to quote $90, while ‘B. Riley Securities’ rates the stock as ‘Buy’.
In other news, BERMAN RICHARD J, Director sold 7,250 shares of the company’s stock on Dec 01. The stock was sold for $142,316 at an average price of $19.63. Upon completion of the transaction, the Director now directly owns 0 shares in the company, valued at $0.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 16, Director BERMAN RICHARD J sold 2,708 shares of the business’s stock. A total of $116,588 was realized by selling the stock at an average price of $43.05. This leaves the insider owning 107,203 shares of the company worth $2.45 million. Insiders disposed of 17,761 shares of company stock worth roughly $0.41 million over the past 1 year. A total of 1.87% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in CYRX stock. A new stake in Cryoport Inc. shares was purchased by CITADEL ADVISORS LLC during the first quarter worth $5,005,000. CUBIST SYSTEMATIC STRATEGIES, LLC invested $2,450,000 in shares of CYRX during the first quarter. In the first quarter, SILVERCREST ASSET MANAGEMENT GROUP LLC acquired a new stake in Cryoport Inc. valued at approximately $2,393,000. HRT FINANCIAL LP acquired a new stake in CYRX for approximately $2,347,000. TWO SIGMA INVESTMENTS, LP purchased a new stake in CYRX valued at around $2,296,000 in the second quarter. In total, there are 272 active investors with 96.00% ownership of the company’s stock.
With an opening price of $20.78 on Tuesday morning, Cryoport Inc. (NASDAQ: CYRX) set off the trading day. During the past 12 months, Cryoport Inc. has had a low of $15.63 and a high of $46.98. As of last week, the company has a debt-to-equity ratio of 0.76, a current ratio of 15.00, and a quick ratio of 14.40. The fifty day moving average price for CYRX is $18.63 and a two-hundred day moving average price translates $27.06 for the stock.
The latest earnings results from Cryoport Inc. (NASDAQ: CYRX) was released for Jun, 2022. According to the Integrated Freight & Logistics Company, earnings per share came in at -$0.23, missing analysts’ expectations of -$0.15 by -0.08. This compares to -$0.14 EPS in the same period last year. The company reported revenue of $60.46 million for the quarter, compared to $56.69 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 6.65 percent. For the current quarter, analysts expect CYRX to generate $70.1M in revenue.
Cryoport Inc.(CYRX) Company Profile
Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.
